Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC25517876;7877;7878 chr2:178773313;178773312;178773311chr2:179638040;179638039;179638038
N2AB25517876;7877;7878 chr2:178773313;178773312;178773311chr2:179638040;179638039;179638038
N2A25517876;7877;7878 chr2:178773313;178773312;178773311chr2:179638040;179638039;179638038
N2B25057738;7739;7740 chr2:178773313;178773312;178773311chr2:179638040;179638039;179638038
Novex-125057738;7739;7740 chr2:178773313;178773312;178773311chr2:179638040;179638039;179638038
Novex-225057738;7739;7740 chr2:178773313;178773312;178773311chr2:179638040;179638039;179638038
Novex-325517876;7877;7878 chr2:178773313;178773312;178773311chr2:179638040;179638039;179638038

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTG
  • RefSeq wild type template codon: CAC
  • Domain: Ig-15
  • Domain position: 19
  • Structural Position: 29
  • Q(SASA): 0.1701
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/L None None 0.017 N 0.476 0.058 0.27855597813 gnomAD-4.0.0 6.8413E-07 None None None None N None 2.98757E-05 0 None 0 0 None 0 0 0 0 0
V/M None None 0.655 N 0.609 0.127 0.356072328145 gnomAD-4.0.0 6.8413E-07 None None None None N None 0 0 None 0 0 None 0 0 0 0 1.65585E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.1128 likely_benign 0.1279 benign -1.125 Destabilizing 0.047 N 0.478 neutral N 0.446930853 None None N
V/C 0.5545 ambiguous 0.5992 pathogenic -0.844 Destabilizing 0.94 D 0.609 neutral None None None None N
V/D 0.1891 likely_benign 0.1881 benign -0.747 Destabilizing 0.418 N 0.619 neutral None None None None N
V/E 0.1639 likely_benign 0.1706 benign -0.736 Destabilizing 0.351 N 0.614 neutral N 0.441607594 None None N
V/F 0.1703 likely_benign 0.1839 benign -0.775 Destabilizing 0.716 D 0.633 neutral None None None None N
V/G 0.1775 likely_benign 0.1837 benign -1.433 Destabilizing 0.213 N 0.629 neutral N 0.457646403 None None N
V/H 0.3845 ambiguous 0.4163 ambiguous -0.85 Destabilizing 0.983 D 0.659 neutral None None None None N
V/I 0.0764 likely_benign 0.0824 benign -0.389 Destabilizing 0.002 N 0.293 neutral None None None None N
V/K 0.2737 likely_benign 0.2635 benign -0.974 Destabilizing 0.418 N 0.612 neutral None None None None N
V/L 0.1704 likely_benign 0.1858 benign -0.389 Destabilizing 0.017 N 0.476 neutral N 0.446810725 None None N
V/M 0.1199 likely_benign 0.139 benign -0.426 Destabilizing 0.655 D 0.609 neutral N 0.445476128 None None N
V/N 0.1444 likely_benign 0.1534 benign -0.837 Destabilizing 0.418 N 0.621 neutral None None None None N
V/P 0.6917 likely_pathogenic 0.6733 pathogenic -0.598 Destabilizing 0.593 D 0.638 neutral None None None None N
V/Q 0.2135 likely_benign 0.2249 benign -0.94 Destabilizing 0.836 D 0.621 neutral None None None None N
V/R 0.2608 likely_benign 0.2519 benign -0.51 Destabilizing 0.716 D 0.658 neutral None None None None N
V/S 0.102 likely_benign 0.1096 benign -1.362 Destabilizing 0.004 N 0.507 neutral None None None None N
V/T 0.0807 likely_benign 0.0914 benign -1.229 Destabilizing 0.001 N 0.33 neutral None None None None N
V/W 0.7495 likely_pathogenic 0.7921 pathogenic -0.956 Destabilizing 0.983 D 0.691 prob.neutral None None None None N
V/Y 0.4517 ambiguous 0.4725 ambiguous -0.649 Destabilizing 0.836 D 0.615 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.